NCT01393678

Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease

A Multicenter, Randomized, Double-blind, 2 Parallel Group, Phase 3 Study of PENNEL Capsule in Chronic Liver Disease

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 220 (actual)
• Sponsor: PharmaKing · Industry
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The drug in this study is combined product of biphenyl dimethyl dicarboxylate (DDB) and garlic oil. This components showed synergistic enhancing effects in previous tests. In phase 2 test, 6 cap three times a day dosage (2cap T.I.D) is better than other dosage. Based on above, this study is phase 3 test to prove efficacy and safety of PENNEL.

Conditions

• Chronic Liver Disease

Interventions

Type	Name	Description
DRUG	NISSEL	Biphenyl Dimethyl Dicarboxylate 25mg ............. 1 cap
DRUG	PENNEL	Biphenyl Dimethyl Dicarboxylate 25mg \& garlic oil 50mg ............. 1cap

Timeline

• Start date: 1997-11-01
• Primary completion: 1998-03-01
• Completion: 1998-05-01
• First posted: 2011-07-13
• Last updated: 2011-07-13

Locations

1 site across 1 country: South Korea